(R)-2-(Aminomethyl)-1-Boc-Pyrrolidine CAS 259537-92-3 Reinheid >98.0% (HPLC) Fabriek

Koarte beskriuwing:

Namme: (R)-2-(Aminomethyl)-1-Boc-Pyrrolidine

CAS: 259537-92-3

Reinheid: >98.0% (HPLC)

Uterlik: kleurleaze of bleek giele floeistof

Hege kwaliteit, kommersjele produksje

E-Mail: alvin@ruifuchem.com


Produkt Detail

relatearre produkten

Produkt Tags

Beskriuwing:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (R)-2-(Aminomethyl)-1-Boc-Pyrrolidine (CAS: 259537-92-3) with high quality, commercial production. Ruifu Chemical offers a wide range of chiral compounds. We can provide Certificate of Analysis (COA), worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Gemyske eigenskippen:

Gemyske namme (R)-2-(Aminomethyl)-1-Boc-Pyrrolidine
Synonimen (R)-2-(Aminomethyl)-1-N-Boc-Pyyrolidine;(R)-2-(aminomethyl)-1-(tert-butoksykarbonyl)pyrrolidine;tert-Butyl (R)-2-(Aminomethyl)-1-Pyrrolidinecarboxylate;(R)-2-(Aminomethyl)-1-Pyrrolidinecarboxylic Acid tert-Butyl Ester
CAS nûmer 259537-92-3
CAT nûmer RF-CC311
Stock Status Op foarried, produksjeskaal oant tonnen
Molekulêre formule C10H20N2O2
Molekuul gewicht 200.28
Kookpunt 98.0 ~ 110.0 ℃/1 mmHg
Tichtheid 1,044±0,06 g/cm3
Refractive Index 1.4680~1.4720
Merk It bedriuw Ruifu Chemical

Spesifikaasjes:

Ûnderdiel Spesifikaasjes
Ferskining Kleurleaze of bleke giele floeistof
Purity / Analyse metoade >98.0% (HPLC)
Optical Purity >98.0% ee
Spesifike Rotation [α]20/D +37.0° ~ +41.0°(C=1, MeoH)
Infraread Spectrometry Konformt oan Struktuer
Proton NMR-spektrum Konformt oan Struktuer
Test Standert Enterprise Standert
Gebrûk chirale ferbiningen;Pharmaceutical Intermediates

Pakket en opslach:

Pakket: Fluorinated Bottle, 25kg / Drum, of neffens klant syn eask

Opslach betingst:Bewarje yn fersegele konteners op in koel en droech plak;Beskermje fan ljocht en focht

Foardielen:

1

FAQ:

Oanfraach:

(R)-2-(Aminomethyl)-1-Boc-Pyrrolidine (CAS: 259537-92-3) wurdt brûkt as in farmaseutyske intermediate.

Skriuw jo berjocht hjir en stjoer it nei ús